AeroVironment lands Border Patrol contract
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Engie U.S. Wind inks deal with Walmart
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →ZPower teams up with San Jose firm to deliver rechargeable batteries
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Bank of the Sierra reports third quarter earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Melchiori pleads guilty to felonies in fraud, theft case
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Lemon grower goes digital with app promoting good health
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen gets go-ahead on two drugs
Regulators handed Amgen two victories for its drug portfolio, granting the Thousand Oaks biotech giant approval to treat a wider range of patients with osteoporosis and blood disorders. The U.S. Food and Drug Administration approved the use of Amgen’s immune thrombocytopenia drug Nplate for earlier use in adults Oct. 18, allowing it to be given Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
